Clinical Trials Research: Challenges of Patient Education and Informed Consent

Nancy Jo Bush

ONF 2005, 32(4), 737-739. DOI: 10.1188/05.ONF.737-739

Jump to a section

    References

    Erikson, J., & Kuck, A.W. (2001). Biotherapy. In E.M. Lin (Ed.), Advanced practice in oncology nursing: Case studies and review (pp. 136-150). Philadelphia: Saunders.

    Esper, P., & Knoop, T. (2005). Current topics in colorectal cancer: Targeting VEGF. Retrieved June 6, 2005, from http://www.imeronline.com

    Goh, B.C. (2000). Design of phase I and II clinical trials in oncology and ethical issues involved. Annals of the Academy of Medicine, Singapore, 29, 588-597.

    Polit, D.F., & Beck, C.T. (2004). Nursing research: Principles and methods (7th ed.). Philadelphia: Lippincott Williams and Wilkins.

    Albrecht, T.L., Blanchard, C., Ruckdeschel, J.C., Coovert, M., & Strongbow, R. (1999). Strategic physician communication and oncology clinical trials. Journal of Clinical Oncology, 17, 3324-3332.

    Brown, R.F., Butow, P.N., Butt, D.G., Moore, A.R., & Tattersall, M.H. (2004). Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Social Science and Medicine, 58, 379-390.

    Cox, K. (2000). Enhancing cancer clinical trial management: Recommendations from a qualitative study of trial participants' experiences. Psycho-Oncology, 9, 314-322.

    Erikson, J. (2001). Educator role. In E.M. Lin (Ed.), Advanced practice in oncology nursing: Case studies and review (pp. 444-455). Philadelphia: Saunders.

    Erikson, J., & Kuck, A.W. (2001). Biotherapy. In E.M. Lin (Ed.), Advanced practice in oncology nursing: Case studies and review (pp. 136-150). Philadelphia: Saunders.

    Flory, J., & Emanuel, E. (2004). Interventions to improve research participants' understanding in informed consent for research: A systematic review. JAMA, 292, 1593-1601.

    Halpern, S.D. (2002). Prospective preference assessment: A method to enhance the ethics and efficiency of randomized controlled clinical trials. Controlled Clinical Trials, 23, 274-288.

    Joffe, S., Cook, E.F., Cleary, P.O., Clark, J.W., & Weeks, J.C. (2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358, 1772-1777.

    Lee, C.O. (2004a). Clinical trials in cancer part I. Biomedical, complementary, and alternative medicine: Finding active trials and results of closed trials. Clinical Journal of Oncology Nursing, 8, 531-535.

    Lee, C.O. (2004b). Clinical trials in cancer part II. Biomedical, complementary, and alternative medicine: Significant issues. Clinical Journal of Oncology Nursing, 8, 670-674.

    Loh, W.Y., Butow, P.N., Brown, R.F., & Boyle, F. (2002). Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent. Cancer, 95, 2414-2421.

    Polit, D.F., & Beck, C.T. (2004). Nursing research: Principles and methods (7th ed.). Philadelphia: Lippincott Williams and Wilkins.

    Schain, WS. (1994). Barriers to clinical trials, part II: Knowledge and attitudes of potential participants. Cancer, 74(9, Suppl.), 2666-2671.